Buckstein Michael, Skubish Samantha, Smith Kimberly, Braccia Irene, Green Sheryl, Rosenzweig Kenneth
Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai, New York, New York.
Adv Radiat Oncol. 2020 May 5;5(4):610-616. doi: 10.1016/j.adro.2020.04.014. eCollection 2020 Jul-Aug.
The coronavirus disease 2019 (COVID-19) pandemic is affecting all aspects of life and changing the practice of medicine. Multiple recommendations exist on how radiation oncology practices should deal with this crisis, but little information is available on what actually happens when the COVID-19 surge arrives. New York City experienced the first surge of COVID-19 in the United States and is now the epicenter of the global pandemic. This study reviews how COVID-19 has affected aspects of medicine, nursing, radiation therapy, and administration in a hospital system in New York.
A retrospective review was conducted of the department of radiation oncology in a single health system in New York from March 1, 2020, to April 1, 2020. Collaboration was obtained from physicians, nurses, radiation therapy staff, and administration to recall their policies and effect on specific duties. A timeline was reconstructed to chronicle significant events. Numbers were obtained for patients on treatment, treatment breaks, and COVID-19 infections among staff and patients.
The COVID-19 surge has had a tremendous effect on the health system, such as cessation of all of surgeries, including oncologic surgery, and transfer of all inpatient oncology services to makeshift outpatient facilities. Radiation oncology has made aggressive efforts to reduce the number of patients in treatment to protect patients and staff and to reallocate staff and space for more acute clinical needs. Patients on-beam were reduced by 27% from 172 to 125 by April 1. Almost all visits were changed to telemedicine within 2 weeks. Infection rates and quarantine were quite low among staff and patients. The majority of residents were deployed into COVID-19 clinical settings.
Although we "planned for the worst," our health system was able to make necessary changes to still function at a reduced capacity. Our experience will give other departments a concrete experience to help them make their own policies and manage expectations.
2019年冠状病毒病(COVID-19)大流行正在影响生活的方方面面,并改变着医学实践。关于放射肿瘤学实践应如何应对这场危机,存在多项建议,但对于COVID-19激增到来时实际发生的情况,可用信息却很少。纽约市经历了美国首次COVID-19激增,现在是全球大流行的中心。本研究回顾了COVID-19如何影响纽约一家医院系统中的医学、护理、放射治疗和行政管理等方面。
对纽约一个单一卫生系统中放射肿瘤学部门在2020年3月1日至2020年4月1日期间进行了回顾性研究。从医生、护士、放射治疗工作人员和行政管理人员处获得合作,以回忆他们的政策及其对特定职责的影响。重建了一个时间表来记录重大事件。获取了正在接受治疗的患者数量、治疗中断情况以及工作人员和患者中的COVID-19感染人数。
COVID-19激增对卫生系统产生了巨大影响,例如所有手术(包括肿瘤手术)停止,所有住院肿瘤服务转移到临时门诊设施。放射肿瘤学已积极努力减少接受治疗的患者数量,以保护患者和工作人员,并重新分配工作人员和空间以满足更紧急的临床需求。到4月1日,正在接受治疗的患者从172人减少了27%,降至125人。几乎所有就诊在2周内都改为了远程医疗。工作人员和患者中的感染率和隔离率相当低。大多数住院医生被部署到COVID-19临床环境中。
尽管我们“做了最坏的打算”,但我们的卫生系统仍能够做出必要的改变,以在能力降低的情况下继续运作。我们的经验将为其他部门提供具体经验,帮助他们制定自己的政策并管理预期。